Drugs / ARTNEO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06032442 | Mar 2022 → May 2023 | osteoarthritis, knee | NPO Petrovax | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 6
| Date | Issuer | Release |
|---|---|---|
| 2024-10-30 | NPO Petrovax | Results Modern treatment methods help to prolong and improve the lives of comorbid patients petrovax.com ↗
Results of recent studies of the Artneo ® complex, which includes undenatured type II collagen, showed a reduction in pain, stiffness and an improvement in functional state of joints and quality of life of patients with osteoarthritis after just 2 months of use. |
| 2024-09-24 | NPO Petrovax | Results Experts present research on osteoarthritis treated with Artneo® complex petrovax.com ↗
Clinical studies support the use of Artneo ® to significantly reduce pain and improve joint function in osteoarthritis [ 1 ] , [ 2 ] . |
| 2024-02-02 | NPO Petrovax | Results Therapeutic Archive publishes results of open-label randomized prospective study of efficacy of Artneo® in patients with knee osteoarthritis petrovax.com ↗ |
| 2023-10-27 | NPO Petrovax | Results Rheumatology Days: doctors share how to improve joint health petrovax.com ↗
She says that, according to MRI data obtained during the study, Artneo ® helps reduce symptoms and stabilizes the cartilage condition. |
| 2023-09-26 | NPO Petrovax | Results Leading Russian orthopedists and rheumatologists discuss comprehensive approach to treating osteoarthritis petrovax.com ↗
According to the data presented by Lyudmila Alekseeva, the Artneo ® group showed a halved WOMAC pain score in 48.1% of patients, and a more than twofold reduction in stiffness according to the WOMAC was noted in 41.3% of people. |
| 2023-09-19 | NPO Petrovax | Results Leading Russian rheumatologists share promising study results petrovax.com ↗
The expert discussed results of an open randomized single-center prospective comparative study of |
All press releases naming this drug 7 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-10-30 | NPO Petrovax | Modern treatment methods help to prolong and improve the lives of comorbid patients petrovax.com ↗ |
| 2024-09-24 | NPO Petrovax | Experts present research on osteoarthritis treated with Artneo® complex petrovax.com ↗ |
| 2024-02-02 | NPO Petrovax | Therapeutic Archive publishes results of open-label randomized prospective study of efficacy of Artneo® in patients with knee osteoarthritis petrovax.com ↗ |
| 2023-10-27 | NPO Petrovax | Rheumatology Days: doctors share how to improve joint health petrovax.com ↗ |
| 2023-09-26 | NPO Petrovax | Leading Russian orthopedists and rheumatologists discuss comprehensive approach to treating osteoarthritis petrovax.com ↗ |
| 2023-09-19 | NPO Petrovax | Leading Russian rheumatologists share promising study results petrovax.com ↗ |
| 2021-06-17 | NPO Petrovax | New complex for maintaining joints and spine health — ARTNEO® petrovax.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARTNEO | “dietary supplement ARTNEO (ARTNEO®), capsules with an average weight of 585 mg” NCT06032442 ↗ |